Cutaneous manifestations among COVID 19 patients admitted to a COVID hospital in South India

Authors

  • Babitha Sukhavasi Post Graduate, Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India
  • Krishna Rajesh Kilaru Associate Professor, Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India
  • Pooja Munnangi Assistant Professor, Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India
  • Akhila Devi Lanka Post Graduate, Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India
  • Kavya Chekuru Post Graduate, Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India
  • Manogna Chowdary Kilaru Medical Student, NRI Medical College and General Hospital, Chinakakani, Guntur, Andhra Pradesh, India

Keywords:

COVID-19, Skin, Cutaneous manifestations.

Abstract

Introduction: COVID‐19 disease is caused by SARS COV-2 virus. Though it primarily affects the lower respiratory tract, recent reports have indicated that specific cutaneous manifestations are associated with COVID-19.
Aim: To identify the cutaneous manifestations present among COVID-19 infected patients. Methods: A descriptive study on patients with active COVID-19 disease at a designated district COVID hospital was conducted for two months from Sept 1 to Oct 31, 2020. The demographics, severity of COVID disease, and co-morbidities were noted. The cutaneous examination was done to record the type of rash, site, and symptoms of rash. The results were statistically analyzed. Results: 1065 patients were included in our study, with 626 males and 439 females. The COVID disease severity was mild in 88.08% of patients. 48 cases (4.51%) had skin manifestations, of which 52.08% were males, and 47.92% were females. The majority, 33.34% of patients with skin manifestations, were in the age group of over 60 years, followed by 31.25 % of patients in the 41 – 60 years age group. 89.58% of these patients developed skin rash after the appearance of COVID symptoms. 85.42% of patients with rash had mild COVID disease. The most common symptom was itching (70.83%). Urticaria and Pruritus were the most common manifestations (25%), followed by Vesiculopapular Rash, Acral Erythema, Maculopapular Rash, Irritant Contact Dermatitis, Aphthous Ulcer, Herpes Zoster, Purpura, and others. The most common site of rash was the abdomen (29.17%).Conclusion: Prevalence of cutaneous manifestations among COVID-19 patients was 4.51% in our study, but more extensive research is required to further our knowledge on the relation between skin and COVID-19.

Downloads

Published

2021-01-09

How to Cite

Sukhavasi, B., Kilaru, K. R., Munnangi, P., Lanka, A. D., Chekuru, K., & Kilaru, M. C. (2021). Cutaneous manifestations among COVID 19 patients admitted to a COVID hospital in South India. International Journal of Health and Clinical Research, 4(1), 9–13. Retrieved from https://www.ijhcr.com/index.php/ijhcr/article/view/691